Literature DB >> 18225983

Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.

Andreas F Widmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18225983     DOI： 10.1086/526528

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

Review 1.  [New antibiotics: small or big advances?].

Authors:  R Draenert; J R Bogner
Journal:  Internist (Berl)       Date:  2009-10       Impact factor: 0.743

2.  Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.

Authors:  P Tattevin; L Basuino; D Bauer; B A Diep; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

3.  Recent advances in antibacterial drugs.

Authors:  Jaswant Rai; Gurpreet Kaur Randhawa; Mandeep Kaur
Journal:  Int J Appl Basic Med Res       Date:  2013-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.